Treatment of Acanthamoeba keratitis.
Niszl
I A
IA
Markus
M B
MB
D000048:Acanthamoeba / Q000302:isolation & purification; D015823:Acanthamoeba Keratitis / Q000175:diagnosis / Q000188:drug therapy*; D000818:Animals; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001550:Benzamidines / Q000627:therapeutic use*; D002710:Chlorhexidine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans
D000891:Anti-Infective Agents, Local; D000981:Antiprotozoal Agents; D001550:Benzamidines; C046651:propamidine isethionate; D002710:Chlorhexidine